Seelos Therapeutics (STU:NXE) FFO


STU:NXE Seelos Therapeutics Inc STU:NXE
16 GF Score
Price €339.84
View Full Analysis

What is Seelos Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:NXE
16GF Score
Seelos Therapeutics Inc STU:NXE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seelos Therapeutics Business Description

Address 300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
16GF Score

Get the complete analysis for STU:NXE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€339.84
Price